THE RESULTS OF THE TOKYO TRIAL OF PREVENTION OF POST-ERCP PANCREATITIS WITH RISPERIDONE (TOKYO P3R)

(1) Gastroenterology, University of Tokyo

(2) Gastroenterology, The Red Cross Medical Center

(3) Gastroenterology, JR Tokyo General Hospital, Tokyo

(4) Gastroenterology, Teiklyo University Chiba Medical Center, Chiba

(5) Gastroenterology, Mitsui Memorial Hospital

(6) Gastroenterology, Kanto Central Hospital, Tokyo, Japan



This item was part of the ENDOSCOPY AND IMAGING II session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Endoscopy 2009; 41 (Suppl 1) A376